ME Therapeutics Holdings, Inc. (TSE:METX) has released an update.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
ME Therapeutics Holdings Inc., a biotech firm specializing in Immuno-Oncology, has announced a non-brokered private placement aimed at raising $1.55 million. The funds are planned to support the company’s research and development, regulatory processes, and general operating needs. The private placement comprises units priced at $1.00, with each unit including a share and a warrant, potentially accelerating if certain trading conditions are met.
For further insights into TSE:METX stock, check out TipRanks’ Stock Analysis page.